Abstract B136: Plasma EGFR mutation detection using a combined exosomal RNA and circulating tumor DNA approach in patients with acquired resistance to first-generation EGFR-TKIs | Citedby Results | Molecular Cancer Therapeutics | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Abstract B136: Plasma EGFR mutation detection using a combined exosomal RNA and circulating tumor DNA approach in patients with acquired resistance to first-generation EGFR-TKIs

Mol Cancer Ther (2015) 14 (12_Supplement_2): B136.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Noncoding RNome as Enabling Biomarkers for Precision Health

Jit Kong Cheong
Dimple Rajgor
Yang Lv
Ka Yan Chung
Yew Chung Tang
He Cheng

International Journal of Molecular Sciences (2022) 23 (18): 10390.

Exosomes in lung cancer diagnosis and treatment. From the translating research into future clinical practice

Christos Masaoutis
Chrysovalantou Mihailidou
Gerasimos Tsourouflis
Stamatios Theocharis

Biochimie (2018) 151: 27.

Pathology Issues in Thoracic Oncology: Histologic Characterization and Tissue/Plasma Genotyping May Resolve Diagnostic Dilemmas

Ibiayi Dagogo-Jack
Andreas Saltos
Alice T. Shaw
Jhanelle E. Gray

American Society of Clinical Oncology Educational Book (2017) (37): 619.

Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer

Nicola Normanno
Marc G. Denis
Kenneth S. Thress
Marianne Ratcliffe
Martin Reck

Oncotarget (2017) 8 (7): 12501.

Extracellular Vesicles Move Toward Use in Clinical Laboratories

Lindsay N. Strotman
Mark W. Linder

Clinics in Laboratory Medicine (2016) 36 (3): 587.